Additionally, mental health conditions and obesity often coexist, making combination therapy clinically appropriate for many individuals
Just make sure that safety, formulation, and dosage are considered
The ability of tirzepatide to positively impact various cardiovascular risk factors suggests its potential for long-term cardiovascular protection
Silibinin has been proven to inhibit the upregulation of co-stimulatory molecules and major histocompatibility complex (MHC) class II molecules on lipopolysaccharide (LPS) stimulated mature DCs, while also suppressing the release of pro-inflammatory cytokines IL-12, IL-23, and TNF-, as well as CD4 + T cell proliferation and Th1/Th17 function, indicating strong immunosuppressive activity (112)
Some evidence suggests that daily treatment with 600 mg of Myo-Inositol and 83 mcg of selenium may help improve thyroid function in people with Hashimotos (18,19)
How do you see it fitting into future treatment pathways